CDK4/6-IN-13

Compounds 10B and 10C are potent and selective cdk4/6 inhibitors exhibiting low nanomolar activity and favorable drug-like properties. They are valuable research tools for studying cell cycle progression and have demonstrated antiproliferative efficacy in both cellular assays and in vivo cancer models.